The government has expressed interest in introducing an oral antiviral drug for COVID-19 by the end of the year, with Prime Minister Fumio Kishida saying that such treatments could become a “key trump card” in the prolonged, uphill battle against the coronavirus.
Japan’s vaccine rollout is set to start in less than two weeks. But with the rollout in other countries, including the U.S., not going as smoothly as authorities would have wanted, there are worries that it could be chaotic for Japan, too.
Government to compensate for side effects, in bid to secure stable supply
TOKYO — Japan’s government plans to cover compensation for any health problems that may arise here from coronavirus vaccines, seeking to ensure a stable supply from foreign manufacturers as global competition intensifies, Nikkei has learned.
Japanese drugmakers are accelerating their development of vaccines for the novel coronavirus even as foreign rivals seem to be leading the global race, with the government pushing homegrown efforts to secure stable supplies for the country.
The lack of results have raised doubts about its approval by the end of this month
Avigan, a candidate drug for treating COVID-19, has not shown apparent efficacy in treating the respiratory disease in clinical trials so far, raising doubts about its approval by the end of this month as sought by the government, sources familiar with the matter said Tuesday.
Drugmaker aims for trials this year with eventual goal of 10 million doses
Japanese drugmaker Shionogi & Co. said Monday that it is developing a coronavirus vaccine with the help of insects and aiming to start clinical trials this year.
The first coronavirus test kits made in Thailand are on their way to laboratories around the country after being delivered to Government House on Thursday (April 16). Developed by Siam Bioscience and the Department of Medical Science, the RT-PCR virus test kits meet World Health Organisation standards and will go straight into battle against the nationwide pandemic.
Pandémies – réalisé par Bensadoun Sophie pour CNRS Images 2021
Phénomène complexe, une pandémie est un invariant de l'homme pris dans son environnement. En effet, du néolithique à nos jours, de la peste bovine au Sars-Cov-2, l'émergence de nouvelles maladies infectieuses résulte souvent des transformations que les humains imposent à leur environnement. L'émergence d'une crise sanitaire mondiale en 2020 est un véritable signal d'alerte sur les usages du vivant. Dans ce documentaire, découvrez comment les biologistes, les anthropologues, les mathématiciens ou encore les historiens peuvent aider à tirer les leçons de la crise sanitaire du Covid-19 et éviter qu'une nouvelle pandémie paralyse à nouveau nos sociétés.